Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Delta Air Lines, Inc. (DAL) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Delta Air Lines, Inc.Trade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Delta Air Lines, Inc. vs Health Care Select Sector SPDR Fund — how do they compare? Delta Air Lines, Inc. trades at $79.19 (market cap $54.02B), while Health Care Select Sector SPDR Fund trades at $168.16 (market cap $43.48B). The key difference: Delta Air Lines, Inc. is the larger of the two by market cap, and Delta Air Lines, Inc. pays a 1.05% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Delta Air Lines, Inc. for 97 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

DALXLV
Market Cap
$54.02B$43.48B
Volume
9,632,84511,121,431
Sector
Industrials—
52-Week High
$93.66$175.68
52-Week Low
$55.65$141.95
Typical Hold Time
97 Days100 Days
Enterprise Value
$69.34B—
Dividend Yield
1.05%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Delta Air Lines, Inc.

Delta Air Lines (DAL) trades at $82.97, down 0.82% on the day, with technical indicators showing bearish momentum despite strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue growth has been steady, reaching $63.36 billion in 2025, while profitability metrics remain solid with a 5.78% net income margin and 20.12% ROE. Analyst sentiment remains overwhelmingly positive with 82% buy ratings and a $103.36 consensus price target representing 25% upside potential.

DAL presents a compelling investment case with attractive valuation multiples (P/E of 13.76, P/S of 0.8) and strong cash flow generation, though near-term headwinds include fuel cost volatility and competitive pressures. The stock's technical weakness contrasts with fundamental strength, creating potential opportunity for patient investors. Key risks include oil price sensitivity and execution challenges in maintaining premium customer loyalty against aggressive competitor tactics.

Health Care Select Sector SPDR Fund

XLV trades at $168.81, up 1.03% today, with a bullish technical signal driven by moving averages. The ETF holds 61 healthcare stocks from the S&P 500, offering broad sector exposure at a low 0.08% expense ratio. Recent news highlights its defensive appeal amid market volatility and potential Fed rate hikes, with articles comparing it favorably to peers like IBB and PJP on cost and diversification.

Outlook is positive given healthcare's defensive growth profile and XLV's cost efficiency, but risks include political uncertainty from midterm elections and sector-specific volatility from drug trial outcomes. Wall Street sentiment is constructive, with the ETF near key resistance at $170.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DAL
76% Buy24% Sell
Avg holding period · 97 Days
XLV
53% Buy47% Sell
Avg holding period · 100 Days

Top news

Latest headlines on both assets

About Delta Air Lines, Inc.

Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.

Read more on DAL →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →